Cargando...
ETFMG Treatments, Testing and Advancements ETF (GERM)
Equity · Estados Unidos
GERM · AMEX · Amplify · domicilio Estados Unidos
Yield actual
1.23%
Índice GW
102.77
TER anual
0,68%
Patrimonio
9,68 M USD
- Política:
- De distribución — confirmada por los pagos observados
- Valor liquidativo:
- 19,34 USD
- Clase de activo:
- Equity
- Posiciones:
- 57
- Inicio:
- 2020-06-18
- Divisa de cotización:
- USD
Índice GW calculado con 4.21 años de historia.
Qué hace este fondo
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.